These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8511754)

  • 1. The effect of secreted heparin-binding proteins on heparin binding to platelets.
    Horne MK
    Thromb Res; 1993 Apr; 70(1):91-8. PubMed ID: 8511754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serglycin-binding proteins in activated macrophages and platelets.
    Kolset SO; Mann DM; Uhlin-Hansen L; Winberg JO; Ruoslahti E
    J Leukoc Biol; 1996 Apr; 59(4):545-54. PubMed ID: 8613703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.
    Visentin GP; Ford SE; Scott JP; Aster RH
    J Clin Invest; 1994 Jan; 93(1):81-8. PubMed ID: 8282825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet factor 4 does not promote von Willebrand factor binding to human platelets.
    Levine SP; Moake JL
    Thromb Res; 1984 Nov; 36(3):233-43. PubMed ID: 6440307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micropatterned array to assess the interaction of single platelets with platelet factor 4-heparin-IgG complexes.
    Medvedev N; Palankar R; Krauel K; Greinacher A; Delcea M
    Thromb Haemost; 2014 May; 111(5):862-72. PubMed ID: 24452831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.
    Prechel MM; Jeske WP; Walenga JM
    Thromb Res; 2010 Apr; 125(4):e143-8. PubMed ID: 19931120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis.
    Kowalska MA; Rauova L; Poncz M
    Thromb Res; 2010 Apr; 125(4):292-6. PubMed ID: 20004006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of two heparin-binding proteins from porcine platelets and their homology with human secreted platelet proteins.
    Rucinski B; Poggi A; James P; Holt JC; Niewiarowski S
    Blood; 1983 Jun; 61(6):1072-80. PubMed ID: 6839017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-platelet factor 4/polyanion antibodies mediate a new mechanism of autoimmunity.
    Nguyen TH; Medvedev N; Delcea M; Greinacher A
    Nat Commun; 2017 May; 8():14945. PubMed ID: 28530237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings.
    Greinacher A; Alban S; Omer-Adam MA; Weitschies W; Warkentin TE
    Thromb Res; 2008; 122(2):211-20. PubMed ID: 18262226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a high-yield expression and purification system for platelet factor 4.
    Huynh A; Arnold DM; Moore JC; Smith JW; Kelton JG; Nazy I
    Platelets; 2018 May; 29(3):249-256. PubMed ID: 29172900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absolute immature platelet counts in the setting of suspected heparin-induced thrombocytopenia may predict anti-PF4-heparin immunoassay testing results.
    Chen W; Ha JP; Hong H; Maitta RW
    Transfus Apher Sci; 2018 Aug; 57(4):507-511. PubMed ID: 29661682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles?
    Campello E; Radu CM; Duner E; Lombardi AM; Spiezia L; Bendo R; Ferrari S; Simioni P; Fabris F
    Cytometry B Clin Cytom; 2018 Mar; 94(2):334-341. PubMed ID: 28052584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of heparin on the in vivo release and clearance of human platelet factor 4.
    Rao AK; Niewiarowski S; James P; Holt JC; Harris M; Elfenbein B; Bastl C
    Blood; 1983 Jun; 61(6):1208-14. PubMed ID: 6839021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-Functionalized Adsorbents Eliminate Central Effectors of Immunothrombosis, including Platelet Factor 4, High-Mobility Group Box 1 Protein and Histones.
    Ebeyer-Masotta M; Eichhorn T; Weiss R; Semak V; Lauková L; Fischer MB; Weber V
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human platelet factor 4 and its C-terminal peptides: heparin binding and clearance from the circulation.
    Rucinski B; Niewiarowski S; Strzyzewski M; Holt JC; Mayo KH
    Thromb Haemost; 1990 Jun; 63(3):493-8. PubMed ID: 2402751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet activation in clinical haemodialysis: LMWH as a major contributor to bio-incompatibility?
    Gritters M; Borgdorff P; Grooteman MP; Schoorl M; Schoorl M; Bartels PC; Tangelder GJ; Nubé MJ
    Nephrol Dial Transplant; 2008 Sep; 23(9):2911-7. PubMed ID: 18364368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of platelet factor 4 with the vessel wall.
    Sachais BS; Higazi AA; Cines DB; Poncz M; Kowalska MA
    Semin Thromb Hemost; 2004 Jun; 30(3):351-8. PubMed ID: 15282658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet factor 4 binds to glycanated forms of thrombomodulin and to protein C. A potential mechanism for enhancing generation of activated protein C.
    Dudek AZ; Pennell CA; Decker TD; Young TA; Key NS; Slungaard A
    J Biol Chem; 1997 Dec; 272(50):31785-92. PubMed ID: 9395524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of platelet factor 4 (PF4) on assays of plasma heparin.
    Levine SP; Sorenson RR; Harris MA; Knieriem LK
    Br J Haematol; 1984 Aug; 57(4):585-96. PubMed ID: 6743573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.